ロード中...
Avoiding drug resistance through extended drug target interfaces: a case for stapled peptides
Cancer drugs often fail due to the emergence of clinical resistance. This can manifest through mutations in target proteins that selectively exclude drug binding whilst retaining aberrant function. A priori knowledge of resistance-inducing mutations is therefore important for both drug design and cl...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5078010/ https://ncbi.nlm.nih.gov/pubmed/27057630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8572 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|